RxDoctor Payments Data

Nikos Hollis, NP

Family · Fruita, CONPI 1083163612

Payments from drug & device makers

$721in general payments, 2019–2025

Across 35 payments — averaging $20.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$628
  • Lilly USA, LLC$31
  • Ipsen Biopharmaceuticals, Inc$24
  • Merz Pharmaceuticals, LLC$23
  • Eisai Inc.$15

What the payments were for

  • Food & beverage$721100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$721 in reported general payments places this provider in the 70th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Medicare billing

Part B allowed, 2024
$59,609
Medicare patients
145
Services billed
4,537

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl105$82,934
Nurtec OdtRimegepant Sulfate18$27,997
Buprenorphine65$21,738
UbrelvyUbrogepant12$17,055
Aimovig AutoinjectorErenumab-Aooe19$13,902
Lidocaine35$3,809
Morphine Sulfate ErMorphine Sulfate17$3,612
Tramadol Hcl ErTramadol Hcl39$2,487
Celecoxib43$2,417
Pregabalin63$2,067
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen79$1,945
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen78$1,660
Gabapentin82$1,241
Lubiprostone12$1,121
Clonidine12$1,112

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy$628$17,05512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,182 family providers in Colorado.

Other family in Fruita

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →